Virios Therapeutics (VIRI) Reports Q2 Loss of $0.51/sh
Tweet
Share
E-mailGet Alerts VIRI Hot Sheet
Join SI Premium – FREE
Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.51), versus ($0.14) reported last year.
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Nike beats quarterly estimates as tariff recovery boosts profit
- Nike (NKE) Tops Q4 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
